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Abstract
Background: Differences in rural and urban settings could account for distinct characteristics in the epidemiology
of tuberculosis (TB). We comparatively studied epidemiological features of TB and helminth co-infections in adult
patients from rural and urban settings of Tanzania.
Methods: Adult patients (≥ 18 years) with microbiologically confirmed pulmonary TB were consecutively enrolled
into two cohorts in Dar es Salaam, with ~ 4.4 million inhabitants (urban), and Ifakara in the sparsely populated
Kilombero District with ~ 400 000 inhabitants (rural). Clinical data were obtained at recruitment. Stool and urine
samples were subjected to diagnose helminthiases using Kato-Katz, Baermann, urine filtration, and circulating
cathodic antigen tests. Differences between groups were assessed by χ2, Fisher’s exact, and Wilcoxon rank sum
tests. Logistic regression models were used to determine associations.
Results: Between August 2015 and February 2017, 668 patients were enrolled, 460 (68.9%) at the urban and 208
(31.1%) at the rural site. Median patient age was 35 years (interquartile range [IQR]: 27–41.5 years), and 454 (68%)
were males. Patients from the rural setting were older (median age 37 years vs. 34 years, P = 0.003), had a lower
median body mass index (17.5 kg/m2 vs. 18.5 kg/m2, P < 0.001), a higher proportion of recurrent TB cases (9% vs.
1%, P < 0.001), and in HIV/TB co-infected patients a lower median CD4 cell counts (147 cells/μl vs. 249 cells/μl, P =
0.02) compared to those from urban Tanzania. There was no significant difference in frequencies of HIV infection,
diabetes mellitus, and haemoglobin concentration levels between the two settings. The overall prevalence of
helminth co-infections was 22.9% (95% confidence interval [CI]: 20.4–27.0%). The significantly higher prevalence of
helminth infections at the urban site (25.7% vs. 17.3%, P = 0.018) was predominantly driven by Strongyloides
stercoralis (17.0% vs. 4.8%, P < 0.001) and Schistosoma mansoni infection (4.1% vs. 16.4%, P < 0.001). Recurrent TB
was associated with living in a rural setting (adjusted odds ratio [aOR]: 3.97, 95% CI: 1.16–13.67) and increasing age
(aOR: 1.06, 95% CI: 1.02–1.10).
Conclusions: Clinical characteristics and helminth co-infections pattern differ in TB patients in urban and rural
Tanzania. The differences underline the need for setting-specific, tailored public health interventions to improve
clinical management of TB and comorbidities.
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Background
Worldwide, tuberculosis (TB) is the leading cause of
mortality from an infectious disease surpassing human
immunodeficiency virus (HIV) infection [1]. Globally,
the burden of TB is decreasing, but mortality due to TB
remains high with 1.4 million TB deaths and an esti-
mated 10.4 million new cases in 2015 [1]. The global TB
case detection rate is below 63% and even lower in
Tanzania with a detection rate ranging from 42% to 54%
[2, 3]. This is partly due to frequent delays in TB diagno-
sis in low-income settings [4–8] ranging from 25 to
185 days [5–7]. Delay in TB diagnosis is associated with
increased transmission in the community [9]. A deeper
understanding of the epidemiology of TB is needed in
order to reach the ambitious vision of the End TB strat-
egy of zero TB discrimination, disease suffering, and
deaths by 2035 [10, 11].
In Tanzania the prevalence of TB varies considerably
across regions, and is higher among males, older per-
sons, and those with lower socioeconomic status [2].
Studies have shown different epidemiological features of
TB in urban and rural settings due to differences in
health-seeking behaviour, knowledge of TB transmission,
gender roles, socioeconomic status, and disease burden
[12–14]. Rural-urban characteristics and living condi-
tions could account for differences in the epidemiology
of TB in Tanzania and elsewhere. Comorbidities such as
HIV and helminth co-infections contribute to different
treatment outcomes among TB patients [15–17]. We
studied differences in the epidemiology of TB and co-
morbidities such as helminth co-infections and severe
anaemia from two population-based TB cohort plat-
forms established since 2013 in Tanzania [18].
Methods
Study setting
We included adult patients (≥ 18 years) from an ongoing
prospective cohort of bacteriologically confirmed pul-
monary TB patients in Tanzania (TB-DAR). TB-DAR
was initiated in 2013 as a platform to study clinical and
molecular epidemiology of TB in Tanzania. The study
has two recruitment sites (Fig. 1): one urban site in the
densely populated Temeke district in Tanzania’s eco-
nomic capital, Dar es Salaam, with ~ 4.4 million inhabi-
tants, and one in the rural site found within the Ifakara
ward in the sparsely populated Kilombero district with
~ 400 000 inhabitants [19].
Study sites
Urban site (Dar es Salaam)
The urban site is located in the Temeke District in Dar
es Salaam inhabited by about 1.4 million inhabitants
(Fig. 1). Patient recruitment was done at the TB clinic of
Temeke District Hospital, which is one of three regional
referral hospitals in the city. The hospital is the largest
healthcare facility in the district that provides specialized
care and treatment for the Temeke population. Recruit-
ment of patients started in November 2013 and is on-
going in the second part of 2017 [18, 20–22].
Rural site (Ifakara)
The rural site is located in the Kilombero District with a
population of about 407 000 people [19]. Recruitment
was done at the Chronic Disease Clinic of Ifakara
(CDCI), a clinic for patients infected with HIV and/or
TB at the Saint Francis Referral Hospital (Fig. 1). The
hospital is the largest healthcare facility of the Kilombero
District in the Morogoro Region, located in southern
Tanzania, and provides care for residents of Kilombero
and the nearby Ulanga District [23]. Patient recruitment
started in August 2015 and is ongoing at the time of
manuscript writing.
Study population
We analysed data collected from patients who were con-
secutively enrolled between August 1, 2015 and February
28, 2017. Patients were eligible for enrollment if they
had an age of 18 years or above, lived within the study
area, and gave written informed consent. Patients who
were severely ill were excluded. Of the 672 bacteriologic-
ally confirmed TB patients enrolled in the TB-DAR
study during this time period, we excluded four patients
due to missing complete clinical information (Fig. 2).
Study procedures
At recruitment, patients with confirmed pulmonary TB
were interviewed and underwent physical examination
as previously described [18, 22]. After recruitment, pa-
tients were seen by the study doctor at 6 and 12 months
after initiating TB treatment. Of note, TB treatment
was supervised by home-based or facility-based direct
observation (patient-centered approach) according to
the National guideline [24]. Clinical data and biological
specimens (sputum, serum, plasma, stool, and urine
samples) were collected from all TB patients for labora-
tory analysis.
Laboratory procedures
Microbiological investigations
Bacteriological confirmation of TB was done by examin-
ing the presence of acid fast bacilli (AFB) under fluores-
cence LED microscope or by using Xpert MTB/RIF
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assay (Cepheid; Sunnyvale, USA) in all sputum samples.
AFB smear-positive results were graded according to
published guidelines [24, 25]. All sputum samples were
sent to a biosafety level 2+ TB laboratory for solid cul-
ture on Lowenstein-Jensen medium at the Bagamoyo
Research and Training Center (BRTC), Bagamoyo,
Tanzania (Fig. 1). Sputum samples from Ifakara were
preserved in cetylpyridinium chloride (CPC) and sent by
post to BRTC in Bagamoyo and processed as previously
described [26].
Helminth investigations
For the diagnosis of helminth infections, stool and urine
samples were collected once from each patient before
the start of TB treatment. From the rural site, the sam-
ples were sent to the Ifakara Health Institute Helminth
Laboratory in Ifakara, Tanzania. From the urban site, the
samples were transferred to the Helminth Unit at BRTC
in Bagamoyo. At each laboratory, samples were exam-
ined for helminth infection using standardized, quality-
controlled procedures as previously described [18, 27].
Fig. 1 Map of Tanzania showing the regional tuberculosis (TB) notification rates, the locations of the study sites (triangles), and the TB laboratory
(square). a Overview. b Study site 1 (urban), Temeke District, Dar es Salaam Region (triangle); study site 2 (rural), Ifakara, Kilombero District
(triangle); and the tuberculosis laboratory in Bagamoyo, Pwani Region
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The Kato-Katz method was performed in triplicate with
thick stool smears from each sample to diagnose Ascaris
lumbricoides, hookworm, Schistosoma mansoni, and Tri-
churis trichiura infection. Strongyloides stercoralis infec-
tion was diagnosed by the Baermann method [27].
Microhaematuria was examined by reagent strips
(Hemastix; Siemens Healthcare Diagnostics Inc.; Tarry-
town, USA). Additionally, a point-of-care circulating
cathodic antigen (POC-CCA) urine cassette test (ICT
Diagnostics, Noordhoek, South Africa) was employed
for rapid diagnosis of S. mansoni [28]. S. haematobium
eggs were detected using urine filtration [18, 29]. For
quality control, 10% of the Kato-Katz slides were ran-
domly selected and re-examined by a senior laboratory
technician at each site [27].
Other laboratory investigations
HIV screening was done using the Alere Determine HIV
rapid test (Alere; San Diego, USA) following national
HIV testing algorithms; the Uni-gold HIV rapid test
(Trinity Biotech; Wicklow, Ireland) served as a con-
firmatory test in the event of a positive screening test. In
HIV-positive patients, CD4 cell counts were determined
by flow cytometry (FACS Calibur, Becton Dickinson Bio-
sciences; San Jose, USA) within 3 h after blood was
drawn. A full blood cell count was done with a Sysmex
XP-300 (Sysmex Corporation; Kobe, Japan). Blood tests
were performed at the Ifakara Health Institute (IHI)
laboratories under regular supervision by the quality as-
surance team.
Data collection and definitions
At the time of recruitment, clinical officers from the Ifa-
kara Health Institute with extensive experience in clin-
ical research performed physical examinations and
interviewed patients using standardized questionnaires
[18, 22]. We collected sociodemographic, clinical, and
socioeconomic data from all patients. Data were entered
using tablets via the OpenDataKit application (www.o-
pendatakit.org). Data quality was monitored in real-time
using the “odk_planner” tool [20].
A TB patient was defined as new detection of Myco-
bacterium tuberculosis in the sputum by smear micros-
copy or Xpert MTB/RIF assay [24]. A new TB patient
was defined as a person, who had never been treated or
whose prior treatment for TB had lasted less than
1 month [28]. Recurrent TB patients (relapse patients)
were persons who had been treated previously for TB
and had been declared cured or had completed their
most recent course of treatment, who then presented
with a recurrent episode of TB (either a true relapse or a
new episode of TB caused by reinfection) [28].
Severe anaemia was defined as haemoglobin (Hb) < 8.5
g/dl. Diabetes mellitus was defined as a random or fasting
blood glucose level of ≥11.1 mmol/L or 7 mmol/L [30]. Pa-
tients were considered co-infected with helminths if eggs or
Urban setting
n = 461
Rural setting
n = 211
Eligible for 
analysis
n = 460
Eligible for 
analysis
n = 208
TB patients recruited between August 
2015 until February 2017
n = 672
Total included in the analysis
n = 668
Incomplete 
clinical data
n = 3
Incomplete 
clinical data
n = 1
Fig. 2 Selection of study patients
Sikalengo et al. Infectious Diseases of Poverty  (2018) 7:24 Page 4 of 12
larvae of the following species in stool or urine microscopy
were present: A. lumbricoides, Enterobius vermicularis,
Hymenolepis diminuta, hookworm, S. haematobium, S.
mansoni, S. stercoralis, and T. trichiura. Additionally, S.
mansion infection was defined as a positive POC-CCA
urine cassette test. Two forms of helminth infection were
distinguished: schistosomiasis, due to infection with either
S. mansoni or S. haematobium; and other helminthiases,
which included infection with A. lumbricoides, E. vermicu-
laris, H. diminuta, hookworm, S. stercoralis, or T. trichiura.
Occupational risk for acquiring helminth infection was de-
fined as working in rice fields, car washing, or sand harvest-
ing pits, and fishing in rivers or still bodies of natural
freshwater. TB diagnosis delay was recorded whenever
more than 3 weeks elapsed between occurrence of patient’s
first TB symptom(s) and TB diagnosis was made [22].
Statistical and geographical analysis
Descriptive statistics were employed for characterizing pa-
tients. For continuous variables, the Wilcoxon rank-sum or
Student’s t-tests were used, depending on the distribution
from the two sites, and χ2 or Fisher’s exact tests for com-
parison of categorical variables, as appropriate. We set the
threshold of a statistically significant difference at an alpha
level of 0.05. Univariate and multivariate logistic regression
models were fitted to assess the association between recur-
rent TB with different epidemiological characteristics
among TB patients. Additionally, we analysed the associ-
ation of helminth co-infections and different predictors in
a logistic regression model adjusted for age, sex, HIV infec-
tion, individual deworming history, occupational risk, and
site (urban/rural). All analyses were performed in Stata ver-
sion 13.1 (Stata Corporation; College Station, USA).
We collected geo-coordinates using Android tablets
from the two study sites and the TB laboratory. The
Tanzania regions shapefiles were obtained from the Tan-
zanian National Bureau of Statistics, and merged with
the corresponding annual TB notification rates in 2015
obtained from the National Tuberculosis and Leprosy
Programme. We used ArcGIS version 10.4 (Esri; Red-
lands, USA) to produce the map.
Results
Comparison of patient characteristics in the urban and
rural setting
We studied 668 patients enrolled between August 2015
and February 2017, 460 (68.9%) at the urban and the
remaining 208 (31.1%) at the rural site (Table 1). Their
median age was 35 years (interquartile range [IQR]: 27–
41.5 years), and 454 (68.0%) were males. Rural patients
were older than those from the urban setting (median
age 37 years, IQR: 27–46 years, vs. 34 years, IQR: 27–
40 years; P = 0.003). Prevalence of HIV infection was
similar in the two settings (59/208 [28.4%] in the rural
vs. 108/460 [23.5%] in the urban setting, P = 0.18).
Among HIV-positive patients from the rural setting,
start of anti-retroviral treatment (ART) was delayed after
HIV diagnosis compared to those from the urban setting
(median time to start of ART 24 days [IQR: 11–64 days]
vs. 14 days [IQR: 11.5–20.5 days], P = 0.001). The pro-
portion of a contact history with a TB case was higher in
rural compared to urban patients (20.2%, 95% CI: 14.7–
25.6% vs. 12.8%, 95% CI: 9.8–15.9%, P = 0.014). Body mass
index (BMI) at the time of TB diagnosis was significantly
lower among rural patients than their urban counterparts
(median 17.5 kg/m2 [IQR: 16.2–19.6 kg/m2] vs. 18.5 kg/m2
[IQR: 17–20.3 kg/m2], P < 0.001).
At the time of TB diagnosis, mean Hb levels were
comparable in both groups. Among HIV-positive TB pa-
tients, the median CD4 cell count was lower in the rural
compared to the urban setting (147 cells/μl [IQR: 84–
246 cells/μl] vs. 249 CD4 cells/μl [IQR 131–450 cells/μl],
P = 0.02). Among 630 patients whose blood glucose
levels were tested, 17/630 (2.5%) were diagnosed as dia-
betic. Prevalence of diabetes in the TB patients did not
differ between the two settings.
TB patients in the rural setting were less likely to self-
access anthelminthic medications than urban patients
(73/208 [35.1%] vs. 304/460 [66.1%], P < 0.001) and had
less access to mass deworming campaigns in the last
12 months at the time of recruitment (10/208 [4.8%] vs.
73/460 [15.9%], P < 0.001).
Comparison of recurrent TB cases in the urban and rural
setting
In the rural setting, 18/208 (10.0%) were recurrent (re-
lapse) TB cases compared to 6/460 (1.3%) in the urban
setting. Patients with recurrent TB were older than pa-
tients with a first TB episode (47 years vs. 35 years), 22
of the 24 patients with recurrent TB were males, and 14
were not employed. Rural recurrent TB patients had a
higher median body fat percentage than those from the
urban setting (11.9% vs. 7.1%, P = 0.005). Characteristics
of recurrent TB patients are described in Table 2.
In a multivariate logistic regression model, we found
that rural patients were more likely to have recurrent TB
than urban patients (adjusted odds ratio [aOR]: 3.97, 95%
CI: 1.16–13.67, P = 0.029). Furthermore, for each 1-year
increase in age, the adult TB patient risk of developing re-
current TB increased by 6% (aOR: 1.06, 95% CI: 1.02–1.10,
P = 0.001). We found that patients who were underweight
(BMI < 18.5 kg/m2) had a higher risk of recurrent TB
(aOR: 2.97, 95% CI: 0.85–10.30, P = 0.087; Table 3).
Comparison of helminth co-infections patterns and
associated risk factors in the urban and rural settings
The overall prevalence of helminth co-infections in TB
patients was 23.1%. As shown in Table 4, the prevalence
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Table 1 Sociodemographic and clinical characteristics of adult tuberculosis (TB) patients at the time of diagnosis, enrolled between
August 2015 and February 2017 in Dar es Salaam (urban) and Ifakara (rural), Tanzania
Characteristics All Urban Rural P-value
Total 668 460 208
Age groups in years, n (%) 0.001
18–24 112 (16.8) 78 (17.0) 34 (16.4)
25–33 199 (29.8) 151 (32.8) 48 (23.1)
34–43 220 (32.9) 155 (33.7) 65 (31.3)
≥ 44 137 (20.5) 76 (16.5) 61 (29.3)
Sex, n (%) 0.81
Female 214 (32.0) 146 (31.7) 68 (32.7)
Male 454 (68.0) 314 (68.3) 140 (67.3)
HIV status, n (%)
Negative 497 (74.4) 352 (76.5) 145 (69.7)
Positive 167 (25.0) 108 (23.5) 59 (28.4) 0.18
Unknown 4 (0.6) 0 4 (1.9)
Time to ART initiation in days, median (IQR) 15 (11–35) 14 (11.5–20.5) 24 (11–64) 0.001
Education level, n (%) 0.85
No/primary 552 (82.6) 381 (82.8) 171 (82.2)
Secondary/university 116 (17.4) 79 (17.2) 37 (17.8)
Occupation, n (%) < 0.001
Unemployed 257 (38.5) 100 (21.7) 157 (75.5)
Employed 411 (61.5) 360 (78.3) 51 (24.5)
Smoking status a, n (%) 166 (24.9) 122 (26.5) 44 (21.2) 0.18
Alcohol abuse b, n (%) 158 (23.7) 105 (22.8) 53 (25.5) 0.46
People in the household, n (%) < 0.001
≤ 3 428 (64.1) 315 (68.5) 113 (54.3)
> 3 240 (35.9) 145 (31.5) 95 (45.7)
History of TB contact, n (%) 101 (15.1) 59 (12.8) 42 (20.2) 0.014
Household monthly income, n (%) 0.032
< 100 USD 459 (68.7) 328 (71.3) 131 (63.0)
≥ 100 USD 209 (31.3) 132 (28.7) 77 (37.0)
Patient category < 0.001
New case 643 (96.3) 454 (98.7) 189 (90.9)
Recurrent case 24 (3.5) 6 (1.3) 18 (8.7)
Return after lost to follow-up case 1 (0.2) 0 1 (0.5)
BMI (kg/m2), median (IQR) 18.3 (16.7–20.3) 18.5 (17–20.4) 17.5 (16.2–19.6) < 0.001
BMI categories in kg/m2, n (%) 0.001
Underweight, < 18.5 362 (54.2) 229 (49.8) 133 (63.9)
Normal, 18.5–24.9 278 (41.6) 205 (44.6) 73 (35.1)
Overweight, 25.0–29.9 21 (3.1) 20 (4.4) 1 (0.5)
Obese, ≥ 30 7 (1.1) 6 (1.3) 1 (0.5)
Hb level in g/dl, median (IQR) 11.0 (9.7–12.5) 11.1 (9.9–12.6) 11.0 (9.3–12.1) 0.27
Body fat in %, median (IQR) 10.8 (8.0–14.8) 10.6 (7.8–14.8) 11.5 (8.3–14.8) 0.087
Diagnosis delay in weeks, median (IQR) 4 (3–8) 4 (3–6) 8 (4–12) < 0.001
Diagnosis delay in weeks, n (%) < 0.001
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Table 1 Sociodemographic and clinical characteristics of adult tuberculosis (TB) patients at the time of diagnosis, enrolled between
August 2015 and February 2017 in Dar es Salaam (urban) and Ifakara (rural), Tanzania (Continued)
Characteristics All Urban Rural P-value
≤ 3 weeks 174 (26.1) 153 (33.4) 21 (10.1)
> 3 weeks 492 (73.9) 305 (66.6) 187 (89.9)
Visiting traditional healers, n (%) 86 (12.9) 26 (5.7) 60 (28.9) < 0.001
Helminth factors, n (%)
Occupational risk c 274 (41.0) 232 (50.4) 42 (20.2) < 0.001
Individual deworming d 377 (56.4) 304 (66.1) 73 (35.1) < 0.001
Part of mass drug campaign d 83 (12.4) 73 (15.9) 10 (4.8) < 0.001
ART Antiretroviral therapy, BMI Body mass index, HIV Human immunodeficiency virus, Hb Haemoglobin level, IQR Inter-quartile range
USD United States Dollars (1 USD = 2171 Tanzanian Shillings, June 2016)
aDefined as current smoking
bAlcohol use defined as drinking alcohol regularly—at least three standard bottles of beer (or equivalent) per day
cOccupational risk for helminth infection defined as working in rice fields, car washing, harvesting sand, or fishing
dDeworming practice in past 12 months
Table 2 Characteristics of recurrent TB cases in urban and rural Tanzania. Patients enrolled between August 2015 and February 2017
in Dar es Salaam (urban) and Ifakara (rural)
Characteristics All Urban Rural P-value
Total, n (%) 24 (100) 6 (25.0) 18 (75.0) < 0.001
Age in years, median (IQR) 47 (33.5–53) 39 (29–47) 47.5 (38–55) 0.20
Male sex, n (%) 22 (91.7) 6 (100) 16 (88.9) 0.55
HIV infection, n (%) 5 (20.8) 1 (16.7) 4 (22.2) 1.0
Education level, n (%) 5 (0.9) 0.55
No/primary school 21 (87.5) 15 (83.3) 6 (100)
Secondary/university 3 (12.5) 3 (16.7) –
Occupation, n (%) 0.002
Unemployed 14 (58.3) – 14 (77.8)
Employed 10 (41.7) 6 (100) 4 (22.2)
Smoking a, n (%) 3 (12.5) 2 (33.3) 1 (5.6) 0.25
Alcohol use b, n (%) 4 (16.7) – 4 (22.2) 0.54
Diabetes mellitus 1 (5.3) – 1 (7.7) –
People in the household, n (%) 0.99
≤ 3 17 (70.8) 4 (66.7) 13 (72.2)
> 3 7 (29.2) 2 (33.3) 5 (27.8)
History of TB contact, n (%) 7 (29.2) 1 (16.7) 6 (33.3) 0.63
Household monthly income, n (%) 0.99
< 100 USD 18 (75.0) 5 (83.3) 13 (72.2)
≥ 100 USD 6 (25.0) 1 (16.7) 5 (27.8)
BMI in kg/m2, median (IQR) 16.9 (16.3–18.4) 16.5 (15.7–17.0) 17.1 (16.5–18.8) 0.14
Body fat in %, median (IQR) 10.9 (7.4–14.9) 7.1 (5.9–8.5) 11.9 (10.2–15.2) 0.005
Hb level in g/dl, median (IQR) 10.8 (10–12) 11.2 (7.2–12.9) 10.5 (10.1–12) 0.79
Visiting traditional healers, n (%) 5 (20.8) 1 (16.7) 4 (22.2) 0.99
Previous use of antibiotics, n (%) 18 (75.0) 3 (50.0) 15 (83.3) 0.14
Any helminth infection, n (%) 5 (22.7) 2 (50.0) 3 (16.7) 0.21
n Number, IQR Interquartile range, HIV Human immunodeficiency virus, USD United States Dollars (1 USD = 2171 Tanzanian Shillings, June 2016)
aDefined as current smoking
bAlcohol use defined as drinking alcohol regularly—at least three standard bottles of beer (or equivalent) per day
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of helminth co-infections was significantly higher in the
urban compared to the rural setting (25.7%, 95% CI:
21.7–29.6% vs. 17.3%, 95% CI: 12.2–22.5%; P = 0.02).
The rural setting had a higher prevalence of S. mansoni
than the urban setting and a lower prevalence of S. ster-
coralis. Figure 3 shows the distinctive pattern of hel-
minth co-infections.
In a multivariate analysis, TB patients from the urban
setting had significantly higher odds of having any
helminth infection at the time of TB diagnosis com-
pared to those from the rural setting (aOR: 2.44, 95%
CI: 1.44–4.14, P = 0.001). TB patients who had taken
anthelminthic medication within 12 months prior to
TB diagnosis had lower odds of having acquired a
helminth infection (aOR: 0.59, 95% CI: 0.39–0.88,
P = 0.009). Neither age, sex, HIV infection, occupational
risk, nor any other cofactor was associated with hel-
minth infection.
Discussion
Among the 668 TB patients from the urban and rural
settings in Tanzania we studied, patients from the rural
setting were older, had a lower average BMI, and lower
median CD4 cell counts in case of HIV co-infection.
Moreover, patients from the rural setting had more fre-
quently recurrent TB. Whereas schistosomiasis was
higher in the rural setting, the overall prevalence of hel-
minth infections was higher in the urban setting, espe-
cially due to S. stercoralis.
We found differences in patient characteristics be-
tween urban and rural settings, such as age, BMI, occu-
pation, as well as health seeking behavior (e.g., use of
antibiotics prior to TB diagnosis and consultation of
traditional healers) as reported previously from rural
Tanzania [31]. The difference in time between HIV diag-
nosis and ART initiation in the two sites is likely ex-
plained by greater distances of rural patients to the
Table 3 Factors associated with recurrent tuberculosis (TB) among TB cases in urban and rural Tanzania
Characteristics Crude Adjusted
n (%) OR (95% CI) P-value OR (95% CI) P-value
Demographics
Age (years) 1.06 (1.04–1.09) < 0.001 1.06 (1.02–1.10) 0.001
Male sex 4.42 (1.18–16.5) 0.027 3.04 (0.73–12.6) 0.13
BMI < 18.5 kg/m2 2.47 (0.99–6.11) 0.051 3.0 (0.85–10.3)) 0.087
Body fat (%) 0.98 (0.91–1.04) 0.50 – – –
Social characteristics
Higher education level a 0.67 (0.2–2.29) 0.52 – – –
Employed 0.44 (0.2–0.99) 0.046 1.52 (0.47–4.87) 0.49
Monthly income > 200 USD 0.76 (0.31–1.89) 0.56 – – –
Living in the rural 6.79 (2.73–16.86) < 0.001 3.97 (1.16–13.67) 0.029
Household members > 3 0.76 (0.32–1.8) 0.53 – – –
History of TB contact 2.5 (1.03–6.04) 0.04 1.66 0.55–5.03 0.37
Individual deworming b 0.38 (0.17–0.89) 0.026 0.59 (0.19–1.76) 0.34
Occupational risk c 1.04 (0.46–2.34) 0.92 – – –
Smoking 0.48 (0.15–1.50) 0.21 – – –
Alcohol abuse 0.70 (0.25–1.96) 0.50 – – –
Comorbidities
HIV infection 1.38 (0.66–2.88) 0.39 0.51 (0.19–1.38) 0.13
Diabetes mellitus 2.93 (0.52–16.60) 0.23 3.25 (0.43–4.65) 0.25
Severe anaemia d, g/dl 1.07 (0.34–3.37) 0.91 – – –
Haematuria 0.3 (0.02–5.10) 0.41 – – –
Any helminth infection 0.99 (0.38–2.65) 1.0 – – –
OR Odds ratio, CI Confidence interval, HIV Human immunodeficiency virus, BMI Body mass index
Logistic regression model adjusted for age, sex, BMI, employment status, setting (urban/rural), history of TB contact in the household, individual deworming, HIV
infection and diabetes
aHigher education level consists of TB patients who completed their secondary of university education
bIndividual deworming habit in the last 12 months prior to TB diagnosis
cOccupational risk for helminth infection defined as working in rice fields, car wash, harvesting sand, or fishing
dSevere anaemia defined as blood haemoglobin (Hb) level < 8.5 g/dl
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treatment center, a factor that has been shown to con-
tribute in treatment delay [31, 32]. Rural patients com-
paratively had increased likelihood of visiting traditional
healers due to poorer access to health facilities [33]. The
resulting delay in seeking medical care has been shown
to contribute to ongoing TB transmission [5, 7, 31, 34].
Helminth co-infections have been associated with rural
residence [35, 36]. In our recent work in Tanzania, we
also found a positive association between TB and
helminth co-infections in an urban setting [18]. The
observed higher prevalence of helminths in the urban
setting could be due to the rapid growth of the city with
poor urban planning and hygiene control. This results in
slum-like dwellings in large parts of the city with higher
risk of infection with helminths [37]. The overall preva-
lence of TB and helminth co-infections we observed was
comparable to previous studies elsewhere in sub-
Saharan Africa [18, 36, 38–41]. The prevalence of S. ster-
coralis, the principal driver of helminthiasis in the urban
setting in the current study, was comparable to that seen
in previous investigations from urban Tanzania and rural
Ghana [18, 42]. The high prevalence of schistosomiasis
we observed in the rural setting is likely to be setting-
specific, with Ifakara Town being close to the Kilombero
Table 4 Frequency distribution of helminth infection among adult TB patients in Dar es Salaam (urban) and Ifakara (rural), Tanzania
Helminth infection All, n (%) Urban Rural P-value
n (%) 95% CI n (%) 95% CI
Total 668 (100) 460 (68.9) 208 (31.1)
Any helminth infection a 154 (23.1) 118 (25.7) 21.7–29.6 36 (17.3) 12.2–22.5 0.018
Soil-transmitted helminths infections b
Strongyloides stercoralis 89 (13.3) 79 (17.2) 14.4–21.5 10 (4.8) 1.9–7.8 < 0.001
Hookworm 45 (6.7) 26 (5.7) 3.7–8.1 19 (9.1) 5.3–13.2 0.12
Ascaris lumbricoides 2 (0.3) – – 2 (1.0) – –
Trichuris trichiura 5 (0.8) 2 (0.4) – 3 (1.4) – –
Schistosomiasis
Schistosoma mansoni b 15 (2.3) 8 (1.7) 0.57–3.1 7 (3.4) 0.9 to 5.9 0.21
Schistosoma mansoni c 53 (7.9) 19 (4.13) 2.4–6.2 34 (16.4) 11.4–21.6 < 0.001
1+ 19 (43.2) 0 – 19 (63.3) – –
2+ 6 (13.6) 0 – 6 (20.0) – –
3+ 19 (43.2) 14 (100) 5 (16.7) – –
Schistosoma haematobium d 19 (2.8) 16 (3.5) 1.9–5.4 3 (1.4) – –
Multiple helminth infection 0.63
None 471 (70.5) 322 (70.0) 65.8–74.2 149 (71.6) 65.5–77.7
Mono-infection 159 (23.8) 108 (23.5) 19.6–27.4 51 (24.5) 18.7–30.3
Infection with ≥2 species 16 (2.4) 10 (2.2) 0.86–3.5 6 (2.9) 0.62–5.2
TB Tuberculosis, POC-CCA Point-of-care circulating cathodic antigen
aIncluding POC-CCA positive tests (Schistosoma mansoni)
bBased on stool microscopy
cBased on POC-CCA test only
dBased on urine filtration
Fig. 3 Frequency distribution of helminth species among adult TB
patients co-infected with any helminth in an urban and rural setting
in Tanzania (in percentage). Numbers on bars represent absolute
numbers, the category “Other” includes Ascaris lumbricoides and
Trichuris trichiura. All positive helminth results were analysed
(including results from patients with multiple helminth infection)
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River. This was also shown in rural areas of the Demo-
cratic Republic of the Congo [43], especially among
those who came in regular contact with natural open
freshwater bodies (e.g., fishermen and rice famers) [44,
45]. Environmental conditions and administration of
anthelminthic medication initiated on an individual basis
or during mass deworming campaigns differed across
our two settings, and these two factors affect prevalence
and patterns of helminth co-infections. When designing
public health interventions, such differences must be
taken into consideration for further improvement of
clinical outcomes in TB patients, as helminth co-
infections alter clinical presentation and immune re-
sponse to infection [18, 38, 39, 41].
The association of recurrent TB with older age and liv-
ing in certain areas has also been observed elsewhere
[46, 47], and particular comorbidities, such as HIV and
diabetes mellitus, have been associated with recurrent
TB [46, 48, 49]. Recurrent TB is more common in HIV-
positive than HIV-negative patients [46, 50, 51], and is
related to poor treatment outcomes [46]. Smoking has
been associated with a three-fold increased risk of devel-
oping recurrent TB in India [52]. However, this finding
could not be confirmed in the present study. Because
most recurrent cases of TB occur within 12 months of
completion of treatment, follow-up after completion of
treatment is important [52, 53].
A limitation of our study was its inability to differ-
entiate reinfection from relapse among recurrent TB
cases because we did not have sputum samples from
prior episodes that would have made possible differ-
entiation by molecular genotyping of M. tuberculosis
isolates. Drug resistance information was also lacking,
except for rifampicin resistance tested by Xpert MTB/
RIF assay. Although multiple techniques were used
for identification of helminth co-infections, the inves-
tigation of a single stool sample in our study could
have resulted in underestimation of the true preva-
lence of infection, especially of hookworm, T. tri-
chiura and A. lumbricoides [54].
Conclusions
The differences in clinical and socio-demographic char-
acteristics of TB patients in urban and rural Tanzania
underline that public health interventions need to be tai-
lored to a given setting to improve clinical outcomes of
TB and mitigate the risk of co-infections. TB patients in
the rural Tanzania are likely to be older with more
recurrent TB cases, have more limited access to anthel-
minthic medication individually, have a longer TB diag-
nosis delay, and seek more frequently care from
traditional healers. The overall prevalence of helminth
co-infections in TB patients was higher in the urban set-
ting, predominantly driven by S. stercoralis infection, but
the prevalence of S. mansoni was higher in the rural set-
ting. These observations may guide public health inter-
ventions that target, for example, traditional healers in
the rural setting, aiming to improve early detection of
TB cases and referral for anti-tuberculosis treatment. On
the other hand, screening and treatment of helminths
among TB patients should be improved, especially in the
urban setting.
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